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Recent years have seen rapid increases in the variety, cost
and complexity of instruments used in analytical
chemistry. Gone are the days when choice was a simple
task and any mistake did not lead to a major financial
embarassment which had to be lived with for perhaps a
decade. Not only is the capital investment required in the
laboratory increasing, but, in the present world economic
climate, the funds available are more limited and have to
be wisely spent.
It is not surprising, therefore, that much attention has
been given to instrument choice and evaluation, particu-
larly by clinical laboratory workers whose large workload
has led to the development of much complex and
expensive automatic equipment. In 1975 colleagues in
New Zealand asked the Expert Panel on Instrumentation
of the International Federation of Clinical Chemistry
(IFCC) ifsomething could be done to ensure that isolated
laboratories have sufficient information from manufac-
turers to enable an intelligent choice of equipment to be
made. The Panel responded over subsequent years by
producing a series of guidelines for the listing of
specifications for various instrument systems. These were
intended to ensure that the manufacturer provided in a
standard format; all the information required by a
potential customer before selecting a particular instru-
ment for purchase. In producing their ’glossy’ literature,
manufacturers have a tendency to leave out important
information which perhaps does not present their instru-
ment in the best light compared with the competition.
Each guideline therefore states-’Manufacturers using
the following guidelines in the description ofinstruments,
should state that they have done so, but if such a
statement is made, no information mentioned in the
guidelines must be excluded unless it does not apply to
the instrument’.
It is unfortunate that only very few manufacturers have
made use of the guidelines and it is easy to think ofmany
reasons for this, not all of which are laudable. To quote
T. D. Geary: ’Perhaps the expense of printing new
brochures could not bejustified by the number ofrequests
for the information. It becomes a circular argument; if
they are not available customers will not ask for them, if
they do not ask for them they will not be made available’.
It would be a great service to the community if more
manufacturers would use the guidelines.
A major factor in the choice of an instrument is to have
access to reliable information on evaluation, and again to
this our clinical colleagues have given much thought. The
situation in 1984 was reviewed in Journal of Automatic
Chemistry by Professor Haeckel (Volume 6, p. 88). It has
been assumed that there will be three stages in the
evaluation of an instrument.
(1) Firstly the manufacturer organizes his own evalua-
tion of prototypes before going into production, and at
this stage he generates the information necessary for
the guideline specifications mentioned earlier. The US
National Committee for Clinical Laboratoy Standards
has produced a protocol for this work.
(2) Secondly the instrument must be evaluated,
ideally, independently, in the field. This work has all
too often been done in an ad hoc manner, at great
expense to all concerned by many potential purchasers
in many countries. The results are not necessarily
published and certainly are not universally accepted.
The European Committee for Clinical Laboratory
Standards has done much work preparing guidelines
for this stage of evaluation and recommends that:
’Instruments should be evaluated in more than one
centre because examples ofthe instruments themselves
may not all perform in the same manner and also
because the environment in different centres will vary.
Such evaluations may be of different types: in several
centres independently [multiple one-centre evalua-
tions]; or in several centres with close co-ordination
[multi-centre evaluations]’. The advantages of the last
approach are: ’(a) Provision of comparable and exten-
sive data on the reliability of new instruments from
several laboratories. Less evaluation work is required
in each individual laboratory since the overall pool of
data is large; (b) A greater degree ofobjectivity than is
likely to be achieved by multiple one-centre evalua-
tions; (c) better availability of information on instru-
ment performance; (d) avoidance ofunnecessary repli-
cation of evaluations; (e) optimal use of expertise and
financial resources; and (f) more effective stimulation
of relevant instrument improvements’.
Several evaluations have now been carried out accord-
ing to this concept, underlining its value and practic-
ability. Notably for the Hitachi 737 analyser 70 000
items ofdata were collected in four laboratories over a
four-month period and 20 routine parameters were
checked on the instrument for imprecision, inaccuracy,
drift effects, range limits, carry-over, practicability and
dependability. All the trials have shown the advan-
tages ofthe multi-centre approach in terms oftime, cost
and professional acceptability of results obtained.
(3) Thirdly, the so-called ’end user’ needs to confirm,
before placing a new instrument on routine analysis
work, that the performance criteria reported from
stages and 2 apply to his instrument and suit his
requirement. The work involved in this should not take
longer than two weeks and has been covered in a
document prepared by the Expert Panel of the IFCC.